Deutsche Bank
PLRX icon

Deutsche Bank’s Pliant Therapeutics PLRX Stock Holding History

Deutsche Bank’s Portfolio PLRX Stock Details PLRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-47,472
Closed -$64.1K – 3701
2025
Q1 		$64.1K Sell
47,472
-2,504,393
-98% -$15.2M ﹤0.01% 3325
2024
Q4 		$33.6M Buy
2,551,865
+1,017,500
+66% +$13.9M 0.01% 728
2024
Q3 		$17.2M Buy
1,534,365
+8,201
+0.5% +$103K 0.01% 877
2024
Q2 		$16.4M Buy
1,526,164
+40,371
+3% +$520K 0.01% 866
2024
Q1 		$22.1M Buy
1,485,793
+500,801
+51% +$8.26M 0.01% 782
2023
Q4 		$17.8M Sell
984,992
-577
-0.1% -$8.77K 0.01% 825
2023
Q3 		$17.1M Sell
985,569
-305,083
-24% -$5.29M 0.01% 743
2023
Q2 		$23.4M Buy
1,290,652
+164,123
+15% +$3.89M 0.01% 725
2023
Q1 		$30M Buy
1,126,529
+811,221
+257% +$23.1M 0.02% 657
2022
Q4 		$6.09M Buy
315,308
+6,690
+2% +$140K ﹤0.01% 1144
2022
Q3 		$6.45M Hold
308,618
– – ﹤0.01% 1120
2022
Q2 		$2.47M Buy
308,618
+286,831
+1,317% +$1.84M ﹤0.01% 1648
2022
Q1 		$153K Buy
21,787
+6,526
+43% +$66.6K ﹤0.01% 3404
2021
Q4 		$206K Buy
15,261
+780
+5% +$12.4K ﹤0.01% 3376
2021
Q3 		$245K Sell
14,481
-445
-3% -$9.44K ﹤0.01% 3461
2021
Q2 		$435K Sell
14,926
-849
-5% -$26.4K ﹤0.01% 3308
2021
Q1 		$620K Buy
15,775
+8,004
+103% +$260K ﹤0.01% 2969
2020
Q4 		$177K Buy
7,771
+2,205
+40% +$55.3K ﹤0.01% 3538
2020
Q3 		$126K Buy
+5,566
New +$139K ﹤0.01% 3437

Other funds holding PLRX

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
MAP
Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return
TGI
TRV GP IV Boston, Massachusetts $267M AUM 965.83% 1-Year Est. Return

Deutsche Bank's PLRX Position: Q2 2025 in Review

Deutsche Bank sold out of Pliant Therapeutics (PLRX) in Q2 2025, closing a stake of 47,472 shares — an estimated $64.1K sold.

Deutsche Bank first reported a position in PLRX in Q3 2020 and held it in 19 quarters. The position peaked at $33.6M in Q4 2024. 114 funds tracked by Wall St. Rank hold PLRX as of Q2 2025.

  • Deutsche Bank reported no remaining Pliant Therapeutics position as of Q2 2025 after selling out during the quarter.
  • Deutsche Bank sold 47,472 Pliant Therapeutics shares in Q2 2025, an estimated $64.1K.
  • Deutsche Bank first reported a position in Pliant Therapeutics in Q3 2020 and held it in 19 quarters.
  • Deutsche Bank's Pliant Therapeutics position peaked at $33.6M in Q4 2024.
  • 114 funds tracked by Wall St. Rank held Pliant Therapeutics as of Q2 2025.

Based on Deutsche Bank's 13F filing for Q2 2025, filed 12 Aug 2025.